Search research articles
Contact Us
Filters
Showing results (81-90 of 317) with videos related to
Page
of 32
Sort By:
Alimentary Pharmacology & Therapeutics
|
June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease?
M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
May 23, 2014
Letter: psychological remission - a future endpoint in inflammatory bowel disease?
M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
December 8, 2015
Letter: management of post-operative Crohn's disease - thiopurines vs adalimumab
M Aguas, P Nos, J P Gisbert
Revista Espanola De Enfermedades Digestivas
|
May 23, 2003
Gastric carcinogenesis and Helicobacter pylori infection
J M Pajares García, J P Gisbert
Revista Espanola De Enfermedades Digestivas
|
July 30, 2008
[Anemia and inflammatory bowel disease]
F de la Morena, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
March 19, 2011
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
J P Gisbert, M Chaparro, M Esteve
Alimentary Pharmacology & Therapeutics
|
February 18, 2017
Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort
M Barreiro-de Acosta, J P Gisbert
The Cochrane Database of Systematic Reviews
|
April 20, 2007
Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers
M Vergara, X Calvet, J P Gisbert
Helicobacter
|
June 3, 1999
Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review
J P Gisbert, J M Pajares, J Valle
Hepato-Gastroenterology
|
June 17, 1999
Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
J P Gisbert, J M Pajares, C Losa
Page
of 32
Search research articles
Search
Showing results (81-90 of 317) with videos related to
Sort By:
Page
of 32
Alimentary Pharmacology & Therapeutics
|
June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease?
M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
May 23, 2014
Letter: psychological remission - a future endpoint in inflammatory bowel disease?
M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
December 8, 2015
Letter: management of post-operative Crohn's disease - thiopurines vs adalimumab
M Aguas, P Nos, J P Gisbert
Revista Espanola De Enfermedades Digestivas
|
May 23, 2003
Gastric carcinogenesis and Helicobacter pylori infection
J M Pajares García, J P Gisbert
Revista Espanola De Enfermedades Digestivas
|
July 30, 2008
[Anemia and inflammatory bowel disease]
F de la Morena, J P Gisbert
Alimentary Pharmacology & Therapeutics
|
March 19, 2011
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
J P Gisbert, M Chaparro, M Esteve
Alimentary Pharmacology & Therapeutics
|
February 18, 2017
Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort
M Barreiro-de Acosta, J P Gisbert
The Cochrane Database of Systematic Reviews
|
April 20, 2007
Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers
M Vergara, X Calvet, J P Gisbert
Helicobacter
|
June 3, 1999
Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review
J P Gisbert, J M Pajares, J Valle
Hepato-Gastroenterology
|
June 17, 1999
Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
J P Gisbert, J M Pajares, C Losa
Page
of 32